SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-Oct-22 7:01 PM View: | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 148,127 | -- | -- | (100%) 148.13K to 0 | |
25-Jan-22 8:03 PM View: | ChemoCentryx, Inc. (CCXI) | 21-Jan-22 | Option Exercise | 37,500 | $15.41 | $577,750.00 | 34% 110.63K to 148.13K | |
24-May-21 7:47 PM View: | ChemoCentryx, Inc. (CCXI) | 20-May-21 | Grant | 7,726 | -- | -- | 8% 102.9K to 110.63K | |
26-May-20 8:39 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-20 | Grant | 4,660 | -- | -- | 5% 98.24K to 102.9K | |
23-May-19 8:58 PM View: | ChemoCentryx, Inc. (CCXI) | 23-May-19 | Grant | 7,724 | -- | -- | 9% 90.52K to 98.24K | |
23-May-18 9:47 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-18 | Grant | 8,421 | -- | -- | 10% 82.1K to 90.52K | |
30-May-17 7:37 PM View: | ChemoCentryx, Inc. (CCXI) | 26-May-17 | Option Exercise | 20,362 | -- | -- | 42% 48.82K to 69.18K | |
24-May-16 6:59 PM View: | ChemoCentryx, Inc. (CCXI) | 21-May-16 | Option Exercise | 11,795 | -- | -- | 32% 37.03K to 48.82K | |
18-Jun-15 8:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 17-Jun-15 | Grant | 10,000 | -- | -- | 9% 110.0K to 120.0K | |
26-May-15 4:57 PM View: | ChemoCentryx, Inc. (CCXI) | 22-May-15 | Option Exercise | 27,027 | -- | -- | 270% 10.0K to 37.03K | |
26-Jun-14 8:56 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 24-Jun-14 | Grant | 10,000 | -- | -- | 10% 100.0K to 110.0K | |
16-Sep-13 8:19 PM View: | ChemoCentryx, Inc. (CCXI) | 13-Sep-13 | Market Purchase | 10,000 | $6.03 | $60,257.00 | 100% 0 to 10.0K | 73% |
21-Jun-13 5:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 19-Jun-13 | Grant | 15,000 | -- | -- | 18% 85.0K to 100.0K | |
22-Jun-12 6:29 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 20-Jun-12 | Grant | 15,000 | -- | -- | 21% 70.0K to 85.0K | |
10-Apr-12 8:01 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Apr-12 | Market Purchase | 20,000 | $1.62 | $32,400.00 | 40% 50.0K to 70.0K | 107% |
11-Aug-11 7:38 AM View: | Keryx Biopharmaceuticals Inc. (KERX) | 10-Aug-11 | Market Purchase | 10,000 | $3.09 | $30,900.00 | 25% 40.0K to 50.0K | 9% |
13-Jul-11 7:31 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 22-Jun-11 | Grant | 15,000 | -- | -- | 60% 25.0K to 40.0K | |
22-Mar-11 6:26 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 22-Mar-11 | Market Purchase | 20,000 | $4.34 | $86,800.00 | 400% 5.0K to 25.0K | (23%) |
02-Mar-09 6:25 PM View: | Pfizer Inc. (PFE) | 26-Feb-09 | Grant | 60,172 | -- | -- | 15% 408.38K to 468.55K | |
02-Mar-09 6:25 PM View: | Pfizer Inc. (PFE) | 26-Feb-09 | Payment of Exercise | 17,404 | $12.70 | $221,031.00 | (4%) 468.55K to 451.15K | (271%) |
25-Feb-09 7:03 AM View: | Pfizer Inc. (PFE) | 23-Feb-09 | Payment of Exercise | 5,326 | $13.27 | $70,676.00 | (1%) 413.63K to 408.3K | (255%) |
03-Mar-08 8:04 PM View: | Pfizer Inc. (PFE) | 28-Feb-08 | Grant | 22,562 | -- | -- | 6% 367.23K to 389.79K | |
03-Mar-08 8:04 PM View: | Pfizer Inc. (PFE) | 28-Feb-08 | Payment of Exercise | 2,306 | $22.55 | $52,000.30 | (< 1%) 389.79K to 387.48K | (91%) |
25-Apr-07 12:01 PM View: | Pfizer Inc. (PFE) | 23-Apr-07 | Market Sale | 17,087 | $26.61 | $454,685.00 | (5%) 375.47K to 358.38K | (70%) |
25-Apr-07 12:01 PM View: | Pfizer Inc. (PFE) | 23-Apr-07 | Market Sale | 3,982 | $26.59 | $105,881.00 | (1%) 358.38K to 354.4K | (70%) |
04-Apr-07 3:10 PM View: | Pfizer Inc. (PFE) | 03-Apr-07 | Gift | 800 | -- | -- | < 1% 372.94K to 373.74K | |
04-Apr-07 3:10 PM View: | Pfizer Inc. (PFE) | 03-Apr-07 | Gift | 1,300 | -- | -- | (< 1%) 373.74K to 372.44K | |
27-Mar-07 4:06 PM View: | Pfizer Inc. (PFE) | 23-Mar-07 | Payment of Exercise | 12,855 | $25.66 | $329,859.00 | (3%) 385.8K to 372.94K | (76%) |
26-Feb-07 5:12 PM View: | Pfizer Inc. (PFE) | 22-Feb-07 | Grant | 47,030 | -- | -- | 14% 338.21K to 385.25K | |
15-Feb-07 9:57 AM View: | Pfizer Inc. (PFE) | 13-Feb-07 | Option Exercise | 69,552 | $18.35 | $1,276,280.00 | 21% 337.82K to 407.38K | |
15-Feb-07 9:57 AM View: | Pfizer Inc. (PFE) | 13-Feb-07 | Market Option Sale | 69,552 | $26.31 | $1,829,910.00 | (17%) 407.38K to 337.82K | (72%) |
24-Apr-06 12:16 PM View: | Pfizer Inc. (PFE) | 21-Apr-06 | Option Exercise | 33,600 | $12.42 | $417,312.00 | 10% 329.1K to 362.7K | |
24-Apr-06 12:16 PM View: | Pfizer Inc. (PFE) | 21-Apr-06 | Market Option Sale | 33,600 | $25.07 | $842,352.00 | (9%) 362.7K to 329.1K | (87%) |
10-Apr-06 12:49 PM View: | Pfizer Inc. (PFE) | 07-Apr-06 | Payment of Exercise | 29 | $26.05 | $755.45 | (< 1%) 329.06K to 329.03K | (80%) |
01-Mar-06 11:37 AM View: | Pfizer Inc. (PFE) | 27-Feb-06 | Payment of Exercise | 2,206 | $26.55 | $58,569.30 | (< 1%) 330.9K to 328.69K | (77%) |
28-Feb-06 11:57 AM View: | Pfizer Inc. (PFE) | 24-Feb-06 | Payment of Exercise | 238 | $26.28 | $6,254.64 | (< 1%) 331.14K to 330.9K | (79%) |
24-Feb-06 5:35 PM View: | Pfizer Inc. (PFE) | 23-Feb-06 | Grant | 54,050 | -- | -- | 20% 277.09K to 331.14K | |
17-Feb-06 1:43 PM View: | Pfizer Inc. (PFE) | 15-Feb-06 | Option Exercise | 4,320 | $15.24 | $65,822.80 | 2% 277.09K to 281.41K | |
17-Feb-06 1:43 PM View: | Pfizer Inc. (PFE) | 15-Feb-06 | Market Option Sale | 4,320 | $25.27 | $109,166.00 | (2%) 281.41K to 277.09K | (86%) |